Prelude Therapeutics Inc (PRLD) — Financial Flexibility Index
Prelude Therapeutics Inc (PRLD) has a Financial Flexibility Index of -0.53x as of September 2025. Free cash flow of $-19.11 Million (operating CF $-19.11 Million minus capex $0.00) represents -1% of total liabilities ($36.22 Million). Check PRLD capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Prelude Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Prelude Therapeutics Inc across 7 annual periods. See Prelude Therapeutics Inc (PRLD) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Prelude Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Prelude Therapeutics Inc. For the full company profile including market capitalisation, see how much is Prelude Therapeutics Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.32x | $-102.12 Million | $-102.89 Million | $44.06 Million | ▲ +9.2% |
| 2023 | -2.55x | $-103.55 Million | $-107.06 Million | $40.58 Million | ▲ +20.8% |
| 2022 | -3.22x | $-80.71 Million | $-83.73 Million | $25.06 Million | ▲ +23.9% |
| 2021 | -4.23x | $-81.21 Million | $-83.53 Million | $19.20 Million | ▼ -5.9% |
| 2020 | -3.99x | $-45.56 Million | $-46.18 Million | $11.41 Million | ▼ -1044.0% |
| 2019 | -0.35x | $-24.89 Million | $-25.66 Million | $71.28 Million | ▼ -9.9% |
| 2018 | -0.32x | $-12.43 Million | $-12.95 Million | $39.10 Million | — |